|
MTMR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.831200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.624200E-01 |
| Normal-vs-Stage2 |
3.535200E-01 |
| Normal-vs-Stage3 |
2.281400E-01 |
| Normal-vs-Stage4 |
3.975000E-01 |
| Stage1-vs-Stage2 |
3.461800E-01 |
| Stage1-vs-Stage3 |
1.680600E-01 |
| Stage1-vs-Stage4 |
4.086000E-01 |
| Stage2-vs-Stage3 |
8.654200E-01 |
| Stage2-vs-Stage4 |
2.669000E-01 |
| Stage3-vs-Stage4 |
1.725360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.413200E-01 |
| Normal-vs-AfricanAmerican |
3.732000E-01 |
| Normal-vs-Asian |
1.716420E-01 |
| Caucasian-vs-AfricanAmerican |
5.843000E-01 |
| Caucasian-vs-Asian |
2.001600E-01 |
| AfricanAmerican-vs-Asian |
4.192200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.232600E-01 |
| Normal-vs-Female |
4.703000E-03 |
| Male-vs-Female |
1.961200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.937600E-01 |
| Normal-vs-Extreme_Weight |
5.434000E-01 |
| Normal-vs-Obese |
8.921700E-02 |
| Normal-vs-Extreme_Obese |
4.952600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.702600E-01 |
| Normal_Weight-vs-Obese |
2.190000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.612000E-01 |
| Extreme_Weight-vs-Obese |
4.529700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.012400E-01 |
| Obese-vs-Extreme_Obese |
9.676100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.827600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.460200E-02 |
| Normal-vs-Age(61-80Yrs) |
8.819000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.277200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.692400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.885700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.190100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.871600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.322200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.543800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.060400E-01 |
| Normal-VS-Type2 PRCC |
8.348600E-01 |
| Normal-VS-KIRP CIMP |
5.197800E-01 |
| Normal-VS-Unclassified PRCC |
3.992200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.314600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.861000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.223700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.968200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.214000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.776400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.542600E-01 |
| Normal-vs-N1 |
3.373400E-01 |
| Normal-vs-N2 |
6.604800E-01 |
| N0-vs-N1 |
2.129400E-01 |
| N0-vs-N2 |
6.146000E-01 |
| N1-vs-N2 |
8.487800E-01 |
|
|
